The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Detaylı Bibliyografya
Asıl Yazarlar:	Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	BMC 2025-01-01
Seri Bilgileri:	BMC Complementary Medicine and Therapies
Konular:	Mild cognitive impairment Alzheimer’s disease Cannabidiol Cannabis-based medicine Patient engagement Patient and public involvement
Online Erişim:	https://doi.org/10.1186/s12906-025-04753-w

Benzer Materyaller

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
Yazar:: Ana Pilar Pérez-Acevedo, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Individualised computerised cognitive training (iCCT) for community-dwelling people with mild cognitive impairment (MCI): results on cognition in the 6-month intervention period of a randomised controlled trial (MCI-CCT study)
Yazar:: Elmar Graessel, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

3D Printed Bigel: A Novel Delivery System for Cannabidiol-Rich Hemp Extract
Yazar:: Anna Gościniak, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
Yazar:: Zackary Montoya, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

El cannabidiol y sus indicaciones en psiquiatría
Yazar:: Juan Fernando Muñoz Ramírez
Baskı/Yayın Bilgisi: (2021-03-01)

Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from <i>Cannabis sativa</i> (Henola Variety) Inflorescences
Yazar:: Anna Stasiłowicz-Krzemień, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Predictors of institutionalization in users of day care facilities with mild cognitive impairment to moderate dementia
Yazar:: Klara Spiegl, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Plasma Pharmacokinetics of Cannabidiol Following Oral Administration of Cannabidiol Oil to Dairy Calves
Yazar:: Kelsey Meyer, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Reasons for using cannabidiol: a cross-sectional study of French cannabidiol users
Yazar:: Davide Fortin, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Cannabidiol use and perceptions in France: a national survey
Yazar:: Clémence Casanova, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Pharmacovigilance on cannabidiol as an antiepileptic agent
Yazar:: Ilaria Ammendolia, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Patterns of cannabidiol use among marijuana users in the United States
Yazar:: Ji-Yeun Park
Baskı/Yayın Bilgisi: (2025-02-01)

The Effects of Cannabidiol on the Driving Performance of Healthy Adults: A Pilot RCT
Yazar:: Toni Marie Rudisill, MS, PhD, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Cannabis sativa and Cannabidiol: A Therapeutic Strategy for the Treatment of Neurodegenerative Diseases?
Yazar:: Milena de Barros Viana, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Cannabidiol Content and In Vitro Biological Activities of Commercial Cannabidiol Oils and Hemp Seed Oils
Yazar:: Masashi Kitamura, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Effects of Cannabidiol on Locomotor Activity
Yazar:: Fabrizio Calapai, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

A Balanced Approach for Cannabidiol Use in Chronic Pain
Yazar:: Donovan A. Argueta, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Comparative Metabolomic Profiling of the Metabolic Differences of Δ9-Tetrahydrocannabinol and Cannabidiol
Yazar:: Qianru Rao, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Current state of knowledge on the use of cannabidiol (CBD) in various medical conditions
Yazar:: Zuzanna Lubczyńska, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract
Yazar:: Paweł Śledziński, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Pharmacokinetics behavior of four cannabidiol preparations following single oral administration in dogs
Yazar:: Sasithorn Limsuwan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Isolation, Purification, and Antimicrobial Characterization of Cannabidiolic Acid and Cannabidiol from <i>Cannabis sativa</i> L.
Yazar:: Laura Daniela Martinenghi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers
Yazar:: Marco Antonio Zenone, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes
Yazar:: Schilling JM, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Disposition of Phytocannabinoids, Their Acidic Precursors and Their Metabolites in Biological Matrices of Healthy Individuals Treated with Vaporized Medical Cannabis
Yazar:: Francesco Paolo Busardò, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Acceptability of and attitudes to the therapeutic use of cannabis and cannabidiol in people with Parkinson’s disease: A French survey
Yazar:: Tangui Barré, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
Yazar:: Diana E. Sepulveda, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Total cannabidiol (CBD) concentrations and yields from traditional extraction methods: Percolation vs. maceration
Yazar:: Jason Wilson, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Cannabidiol (CBD) in the Self-Treatment of Depression-Exploratory Study and a New Phenomenon of Concern for Psychiatrists
Yazar:: Gniewko Wieckiewicz, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
Yazar:: Swapnali Chetia, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Effects of Chronic Cannabidiol Treatment in the Rat Chronic Unpredictable Mild Stress Model of Depression
Yazar:: Zsolt Gáll, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Cannabis Effects on Driving Performance: Clinical Considerations
Yazar:: Brianna Costales, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Production of Cannabidiol Acid Synthase by Chassis Pichia pastoris and of Its Catalytic Activity Analysis
Yazar:: Tingli NIU, ve diğerleri
Baskı/Yayın Bilgisi: (2023-10-01)

What are the informational pathways that shape people’s use of cannabidiol for medical purposes?
Yazar:: Marco A. Zenone, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol
Yazar:: Anjali K. Bhardwaj, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

The Potential of Cannabidiol for Treating Canine Atopic Dermatitis
Yazar:: Ana F. Bizarro, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
Yazar:: John S. Markowitz, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Safety assessment of female sexual hygiene product containing cannabidiol in new zealand white rabbit and clinical trial
Yazar:: Atiwut Kamudhamas, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Yazar:: José A. Crippa, ve diğerleri
Baskı/Yayın Bilgisi: (2018-09-01)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
Yazar:: Luisa Rocha, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)